Correlation Between Sumitomo Dainippon and Genomma Lab
Can any of the company-specific risk be diversified away by investing in both Sumitomo Dainippon and Genomma Lab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sumitomo Dainippon and Genomma Lab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sumitomo Dainippon Pharma and Genomma Lab Internacional, you can compare the effects of market volatilities on Sumitomo Dainippon and Genomma Lab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sumitomo Dainippon with a short position of Genomma Lab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sumitomo Dainippon and Genomma Lab.
Diversification Opportunities for Sumitomo Dainippon and Genomma Lab
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sumitomo and Genomma is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Sumitomo Dainippon Pharma and Genomma Lab Internacional in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genomma Lab Internacional and Sumitomo Dainippon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sumitomo Dainippon Pharma are associated (or correlated) with Genomma Lab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genomma Lab Internacional has no effect on the direction of Sumitomo Dainippon i.e., Sumitomo Dainippon and Genomma Lab go up and down completely randomly.
Pair Corralation between Sumitomo Dainippon and Genomma Lab
Assuming the 90 days horizon Sumitomo Dainippon Pharma is expected to under-perform the Genomma Lab. But the pink sheet apears to be less risky and, when comparing its historical volatility, Sumitomo Dainippon Pharma is 14.79 times less risky than Genomma Lab. The pink sheet trades about -0.65 of its potential returns per unit of risk. The Genomma Lab Internacional is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 76.00 in Genomma Lab Internacional on August 29, 2024 and sell it today you would earn a total of 51.00 from holding Genomma Lab Internacional or generate 67.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 7.46% |
| Values | Daily Returns |
Sumitomo Dainippon Pharma vs. Genomma Lab Internacional
Performance |
| Timeline |
| Sumitomo Dainippon Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Genomma Lab Internacional |
Sumitomo Dainippon and Genomma Lab Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sumitomo Dainippon and Genomma Lab
The main advantage of trading using opposite Sumitomo Dainippon and Genomma Lab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sumitomo Dainippon position performs unexpectedly, Genomma Lab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genomma Lab will offset losses from the drop in Genomma Lab's long position.| Sumitomo Dainippon vs. Hypera SA | Sumitomo Dainippon vs. YourWay Cannabis Brands | Sumitomo Dainippon vs. Cumberland Pharmaceuticals | Sumitomo Dainippon vs. Genomma Lab Internacional |
| Genomma Lab vs. Speakeasy Cannabis Club | Genomma Lab vs. City View Green | Genomma Lab vs. Benchmark Botanics | Genomma Lab vs. Hypera SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |